From the report:
EBITDA increased to $29,055,000 for the half year, up $932,000 on the prior comparative period. EBITDA was impacted by a number of costs incurred in the half year that were outside, or greater than, the normal course of business. These costs included organisational restructuring costs and non-recurring marketing expenditure. The Group continued to actively manage staff costs having regard to increasing resident needs, facility ramp-ups and acquisition integration.
EBIT and profit attributable to members of the parent entity were $22,335,000 and $14,633,000 respectively, both down on the prior comparative period due to an increase in depreciation, financing costs required to fund growth and a one-off tax benefit received last year.
- Forums
- ASX - By Stock
- Will JHC rise more than 10% next Monday?
From the report: EBITDA increased to $29,055,000 for the half...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online